Reagents News and Research

RSS

TriLink BioTechnologies and tebu-bio SA sign distribution agreement

TriLink BioTechnologies, Inc. (TriLink), a leading provider of custom nucleic acid-based compounds, announced it has signed a distribution agreement permitting tebu-bio SA (tebu) to sell its CleanAmp(TM) products. tebu-bio is a European based distributor that supplies over 750,000 reagents and lab services from manufacturers worldwide.

12 Jan 2010

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

SeraCare Life Sciences, Inc. announced today that the Company has added five new, differentiated products to its portfolio to meet the needs of SeraCare’s growing customer base in the life sciences industry.

9 Jan 2010

UMBI announces exclusive licensing of fully human antibody technology platform to Prolias

The University of Maryland Biotechnology Institute (UMBI) today announced the exclusive licensing of a fully human antibody technology platform to Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease.

7 Jan 2010

Biotime ships six ACTCellerate progenitor cell lines to Millipore

BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.

6 Jan 2010

Biological Industries named exclusive distributor of ATCC products in Israel

ATCC today announced a distribution and development partnership with Biological Industries Ltd. to become the exclusive distributor of ATCC products in Israel. The Israel-based organization is now the newest member of the global network of distributors for ATCC.

5 Jan 2010

CBI signs definitive share purchase agreement to acquire GL Biochem

Commonwealth Biotechnologies, Inc. (“CBI”) is pleased to announced it has entered into a revised and binding definitive share purchase agreement to acquire the parent of Shanghai-based GL

4 Jan 2010

CLSI and APHL announce 2010 educational teleconferences

Clinical and Laboratory Standards Institute (CLSI) and Association of Public Health Laboratories (APHL) recently announced the January–June 2010 schedule of educational teleconferences for clinical, public health, and veterinary laboratories.

30 Dec 2009

ICBS targets U.S.regulatory agencies to sell its TOGS 9000 bio-photonic incubation & detection systems

ICBS Ltd., announced today that it will be targeting U.S. state and municipal regulatory bodies for the sale of the TOGS(TM) 9000 bio-photonic incubation & detection systems.

22 Dec 2009

Biovista and Novus Biologicals sign contract for accessing Biovista's BEA literature mining platform

Biovista Inc. today announced the signing of a contract with Novus Biologicals for access to Biovista's BEA literature mining platform. BEA will be used to power Novus Explorer, a new service that Novus Biologicals is offering to visitors of its web site.

18 Dec 2009

Roche Diagnostics and Takara Bio enter into license agreement

Roche Diagnostics and Takara Bio, the Shiga (Japan)-based supplier of systems for use in life science research, announced that they have entered into a license agreement for use of the melting curve analysis technology and SYBR Green techniques in their Kits and Instruments for Real Time PCR.

From Roche Sequencing and Life Science 18 Dec 2009

Idaho Technology signs licensing agreement with Kapa Biosystems

Idaho Technology, Inc. has signed a licensing agreement with Kapa Biosystems, Inc., covering reagents or methods using SYBR® Green I technology and melting curve analysis for real time PCR.

16 Dec 2009

ARKRAY reintroduces the CLIA waived DiaScreen 50 Urine Chemistry Analyzer

ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreen® 50 Urine Chemistry Analyzer.

15 Dec 2009

Vivakor launches new website to promote its remarkable VivaThermic Vial

Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.

14 Dec 2009

New IME-developed cardiac biomarker testing system saves time

Scientists at Singapore's Institute of Microelectronics (IME) have developed a rapid and sensitive integrated system to test simultaneously for specific cardiac biomarkers in finger prick amount of blood.

9 Dec 2009

5AM Venture Management closes $200 million venture capital fund

5AM Venture Management, LLC of Menlo Park, CA and Waltham, MA is pleased to announce the closing of 5AM Ventures III, L.P., a $200 million venture capital fund focused on early-stage life science companies.

8 Dec 2009

Cell Biosciences expands its protein analysis business with Protein Forest acquisition

Cell Biosciences, Inc. today announced that it has acquired Protein Forest, Inc. of Lexington, Massachusetts, a leader in sample preparation technology for proteomic analysis and biomarker discovery.

7 Dec 2009

Cytometry system to precisely control cell movement using sound waves

Applied Biosystems, part of Life Technologies Corporation today announced its entry into the flow cytometry instrumentation market with the debut of the Attune™ Acoustic Focusing Cytometer, a first of its kind cytometry system designed to use sound waves to precisely control the movement of cells.

7 Dec 2009

New data shows patients with Type II PNH cells experience platelet consumption and increased thrombosis risk

Alexion Pharmaceuticals, Inc. today announced presentation of data showing that the presence of Type II paroxysmal nocturnal hemoglobinuria (PNH) cells is correlated with thrombocytopenia, potentially indicating that patients with Type II cells experience ongoing platelet consumption and increased thrombosis risk.

7 Dec 2009

Fluxion Biosciences signs distribution agreement with DI Biotech and Novel Science

Fluxion Biosciences announced today that it has expanded its sales and service network into Asia. The company signed a distribution agreement for its BioFlux™ line with Korea-based DI Biotech. A second agreement with Novel Science covers sales of both the BioFlux and IonFlux™ platforms in Japan. Fluxion has also sold its first BioFlux 1000 system into China.

From Fluxion Biosciences 4 Dec 2009

Kyto advancing with a program for humanization of the mAbTCR23 antibody

Kyto Biopharma Inc., is a biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin B12 platform for the treatment of various forms of cancer.

4 Dec 2009

Reagents News and Research

TriLink BioTechnologies and tebu-bio SA sign distribution agreement

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

UMBI announces exclusive licensing of fully human antibody technology platform to Prolias

Biotime ships six ACTCellerate progenitor cell lines to Millipore

Biological Industries named exclusive distributor of ATCC products in Israel

CBI signs definitive share purchase agreement to acquire GL Biochem

CLSI and APHL announce 2010 educational teleconferences

ICBS targets U.S.regulatory agencies to sell its TOGS 9000 bio-photonic incubation & detection systems

Biovista and Novus Biologicals sign contract for accessing Biovista's BEA literature mining platform

Roche Diagnostics and Takara Bio enter into license agreement

Idaho Technology signs licensing agreement with Kapa Biosystems

ARKRAY reintroduces the CLIA waived DiaScreen 50 Urine Chemistry Analyzer

Vivakor launches new website to promote its remarkable VivaThermic Vial

New IME-developed cardiac biomarker testing system saves time

5AM Venture Management closes $200 million venture capital fund

Cell Biosciences expands its protein analysis business with Protein Forest acquisition

Cytometry system to precisely control cell movement using sound waves

New data shows patients with Type II PNH cells experience platelet consumption and increased thrombosis risk

Fluxion Biosciences signs distribution agreement with DI Biotech and Novel Science

Kyto advancing with a program for humanization of the mAbTCR23 antibody

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News